The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

Hepatocellular carcinoma (HCC), the most common primary liver cancer, is one of the
dreaded complications of chronic liver disease. Recent experimental and clinical studies …

Cancer is associated with a profound perturbation in myelopoiesis that results in the
accumulation of myeloid-derived suppressor cells (MDSCs) to promote disease progression …

There are two types of abnormal hematopoiesis in solid tumor occurrence and treatment:
pathological hematopoiesis, and myelosuppression induced by radiotherapy and …

Transarterial chemoembolization (TACE) has therapeutic effects in patients with
unresectable hepatocellular carcinoma (HCC), but its impact on the cellular immune …

Summary Type 2 diabetes (T2D) and male gender are associated with hepatocellular
carcinoma (HCC) development. We demonstrate that heterozygous deletion of the Ncoa5 …

Hepatectomy is currently considered the most effective option for treating patients with early
and intermediate hepatocellular carcinoma (HCC). Unfortunately, the postoperative …

Results Out of 503 studies searched in databases, 18 studies were included in the meta-
analysis. The pooled analysis with continuous data demonstrated that the IL-6 level in HCC …

Purpose Antiangiogenic therapy is crucial for advanced hepatocellular carcinoma (HCC)
treatment. Interleukin (IL)-6 is an inflammatory response mediator that can promote …

The Relationship Between Serum Interleukin-6 and the Recurre... : Medicine The Relationship
Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular …